# PRC-063 Classroom Study in Children (6-12 Years of Age) With ADHD

> **NCT03172481** · PHASE3 · COMPLETED · sponsor: **Purdue Pharma, Canada** · enrollment: 156 (actual)

## Conditions studied

- ADHD

## Interventions

- **DRUG:** PRC-063 oral capsules
- **DRUG:** Placebo oral capsules

## Key facts

- **NCT ID:** NCT03172481
- **Lead sponsor:** Purdue Pharma, Canada
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2017-05-01
- **Primary completion:** 2017-08-19
- **Final completion:** 2017-12-19
- **Target enrollment:** 156 (ACTUAL)
- **Last updated:** 2019-11-05


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03172481

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03172481, "PRC-063 Classroom Study in Children (6-12 Years of Age) With ADHD". Retrieved via AI Analytics 2026-05-24 from https://api.ai-analytics.org/clinical/NCT03172481. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*